Application Scenarios
Cagrilintide is a non-selective amylin receptor/calcitonin receptor agonist (DACRA). Key application areas include:
Obesity and weight management research: Energy intake, meal size, food reward, and changes in body composition.
Type 2 diabetes/glucose metabolism research: Postprandial glucagon suppression, glycemic variability, and insulin sensitivity.
GLP-1 combination research: Studies on "CagriSema" (cagrilintide + semaglutide) to explore the additive effects of dual satiety pathways.
Neuroendocrine research: Investigating the area postrema, the nucleus tractus solitarius (NTS), the arcuate nucleus of the hypothalamus, and responsiveness to food cues.
Peptide API and formulation development: Lyophilized powders, acetate forms, acylated peptide synthesis, reconstitution stability, and delivery systems.
Scientific/analytical standards: HPLC, mass spectrometry (MS), residual solvent analysis, endotoxin testing, and batch consistency studies.
Clinical Data:
Phase II monotherapy (26 weeks, highest dose): Approximately 10.8% reduction in body weight.
Phase III "REDEFINE 1" trial (CagriSema): Approximately 20.4% reduction in body weight.
As of 2026: Cagrilintide monotherapy has not yet received broad regulatory approval; the New Drug Application (NDA) for CagriSema was submitted to the FDA in December 2025.
Physical and Molecular Mechanisms
Type: A 37-amino acid, lipid-acylated, long-acting amylin analog.
CAS: 1415456-99-3
Molecular Weight (MW): ≈ 4409 Da
Targets: AMY1R / AMY2R / AMY3R (calcitonin receptor [CTR] + RAMP1/2/3) and the calcitonin receptor.
Central effects: Area postrema (brainstem) → satiety; NTS → termination of food intake; hypothalamus/reward system → reduced food cravings.
Peripheral effects: Delayed gastric emptying, suppression of postprandial glucagon, and decreased hepatic glucose output.
Distinctions from GLP-1:
GLP-1 One pathway primarily suppresses the "desire to eat," while the amylin pathway focuses on "how much to eat per meal" and "post-meal cravings." These are distinct but complementary mechanisms.
**Research Value for the Bodybuilding/Contest-Prep Community**
The interest in Cagrilintide within the bodybuilding and contest-prep community stems not from muscle-building potential, but rather from its role in addressing the challenges of a fat-loss phase-namely hunger, binge eating, carbohydrate cravings, and declining training performance.
While GLP-1 agonists may suppress hunger, they do not always eliminate cravings; the amylin pathway helps address hedonic (reward-driven) eating and portion control.
When combined with agents like semaglutide or tirzepatide, it offers a way to study how "multi-layered satiety networks" influence body composition.
**Potential Research Avenues:**
Appetite stability during fat-loss phases.
Responsiveness to cues for snacks, late-night eating, or high-sugar/high-fat foods.
Reduction of fat mass while preserving lean body mass.
Mechanistic support for overcoming "plateaus" encountered during GLP-1 therapy.
**⚠️ Compliance & Safety Warnings:**
These substances are not legal fitness supplements.
Such metabolic peptides are highly sensitive under anti-doping regulations.
Misuse can lead to adverse effects, including nausea, vomiting, gastroparesis, dehydration, gallbladder issues, muscle loss, and electrolyte imbalances.
This entity provides materials strictly for scientific research, raw material supply, or analytical purposes.
**Dietary and Pharmacological Considerations**
**Dietary Aspects:**
Prioritize high protein intake, ensure adequate electrolytes (sodium, potassium, magnesium), and manage hydration.
Avoid heavy, high-fat meals (delayed gastric emptying combined with a high fat load often leads to nausea or acid reflux).
During fat-loss phases, avoid the "triple threat" of extreme caloric restriction, amylin, and GLP-1, as this significantly increases the risk of losing lean body mass.
Increase fiber intake gradually; a sudden, high-fiber diet combined with peptide therapy can place excessive stress on the gastrointestinal tract.
**Combination Use & Risks:**
When used in combination with semaglutide, tirzepatide, or retatrutide, be mindful of gastrointestinal (GI) side effects. Cumulative risks: adverse reactions, dehydration, and tolerability issues.
Co-administration with insulin/sulfonylureas: potential changes in hypoglycemia risk.
Co-administration with drugs having a narrow therapeutic index (e.g., levothyroxine, warfarin, oral contraceptives): delayed gastric emptying may alter drug absorption.
Contraindications/Precautions: History of medullary thyroid carcinoma (MTC) or MEN2, severe gastroparesis, active pancreatitis, pregnancy/lactation, and severe renal or hepatic impairment-exercise extreme caution.
Research-grade materials are not identical to those used in original clinical trials; factors such as purity, endotoxin levels, residual solvents, and lyophilization (freeze-drying) processes can significantly alter experimental outcomes and safety profiles.
Why Choose Us?
We are not mere resellers or "white-label" traders; we are a specialized supply chain provider for research-grade peptides, including Cagrilintide.
✅ Direct-from-Manufacturer
We manage the entire closed-loop process-Solid-Phase Peptide Synthesis (SPPS), acylation, purification, lyophilization, and final packaging-eliminating intermediaries and ensuring full batch traceability.
✅ Professional Production Infrastructure
Equipped with cleanroom production lines, preparative HPLC, mass spectrometry (MS) for identification, and advanced lyophilization systems. We possess deep expertise in the synthesis of long-chain acylated peptides (such as amylin and GLP-1 analogs).
✅ Reliable Supply
Available in small-scale packaging (5 mg / 10 mg / 30 mg) as well as custom synthesis ranging from milligrams to kilograms. We serve peptide brands, research institutions, pharmaceutical formulation developers, and laboratories requiring analytical standards.
✅ High Purity and Consistent Quality
HPLC purity ≥98% or ≥99% (customizable). Each batch includes a Certificate of Analysis (COA), HPLC and MS data, moisture content, residual solvent analysis, and microbial/endotoxin testing (third-party testing available).
✅ Comprehensive After-Sales Support
We provide technical guidance on reconstitution, storage (lyophilized powder at -20°C, protected from light and moisture; reconstituted solutions as per validated conditions), stability, compatibility, and chemical modifications (such as acetylation, PEGylation, or labeling). We also assist with audit and compliance documentation.
FAQ:
Q: Where are your products manufactured?
A: Our products are manufactured in Shenzhen, China.
Q: What is the minimum order quantity (MOQ)? A: The minimum order quantity (MOQ) is 10 bottles/units.
Q: How soon will you ship after an order is placed?
A: For items in stock, shipment is arranged within 24 hours.
Q: What purity levels do you offer?
A: The standard purity is 99%.
Q: Which courier services do you use?
A: We offer shipping via FedEx, DHL, UPS, and postal services.
Q: How long does shipping take?
A: Approximately 10–15 days.
Q: Can you provide a Certificate of Analysis (COA) and an HPLC (High-Performance Liquid Chromatography) test report?
A: Yes, these can be provided; all products undergo professional testing before shipment.
Q: Do you offer OEM (private label) services?
A: Yes, OEM services are available, subject to meeting the minimum order quantity (MOQ) requirements.
Q: How do you handle after-sales issues?
A: If a quality issue attributable to our production is confirmed after the customer has received the goods, we offer free replacement or a refund. We operate with a pragmatic and responsible approach-we address all concerns promptly and properly, without evasion or shifting blame, and are fully committed to protecting our customers' interests.
Q: What payment methods do you accept?
A: We accept bank transfers, Bitcoin, TransferWise, and Xoom.
Hot Tags: chinese supplier of high-purity cagrilintide (5mg/vial) research-grade peptide., China chinese supplier of high-purity cagrilintide (5mg/vial) research-grade peptide. manufacturers, suppliers, factory
